Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic lymphocytic leukemia.

R W Rundles, J O Moore

    Cancer
    |August 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Chronic lymphocytic leukemia (CLL), a common leukemia in Western countries, involves B lymphocyte overgrowth. While manageable for years with chemotherapy, advanced stages present severe symptoms and infections.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Open-Joint Navicular Sheath.

    The Journal of comparative medicine and veterinary archives·2022
    Same author

    Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia.

    Leukemia·2014
    Same author

    Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.

    Leukemia·2012
    Same author

    Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720.

    Leukemia·2011
    Same author

    Hereditary (sex-linked?) anemia.

    The American journal of the medical sciences·2010
    Same author

    Prognosis in the neurologic manifestations of pernicious anemia.

    Blood·2010
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Immunology

    Background:

    • Chronic lymphocytic leukemia (CLL) is the most frequent leukemia in Western nations, primarily affecting older males.
    • CLL is characterized by the accumulation of immunoglobulin-producing B lymphocytes, often leading to hypogammaglobulinemia.
    • Familial clustering suggests a genetic predisposition in some CLL cases.

    Purpose of the Study:

    • To provide a comprehensive overview of Chronic lymphocytic leukemia (CLL).
    • To detail the epidemiology, clinical presentation, and management of CLL.
    • To describe the characteristic features and progression of CLL.

    Main Methods:

    • Review of existing literature on Chronic lymphocytic leukemia (CLL).
    • Analysis of epidemiological data, clinical signs, and symptoms.

    Related Experiment Videos

  • Summary of therapeutic approaches and disease outcomes.

    • Main Results:

    • CLL predominantly affects older men (2:1 ratio) and is linked to B lymphocyte proliferation.
    • Early symptoms include fatigue and lymphadenopathy; advanced disease involves bone marrow failure and infections.
    • Treatment with chlorambucil, cyclophosphamide, and prednisone can control CLL for over a decade.

    Conclusions:

    • Chronic lymphocytic leukemia (CLL) is a manageable malignancy with established treatment protocols.
    • Understanding CLL progression is crucial for managing symptoms and opportunistic infections.
    • Therapeutic strategies aim to prolong remission and improve quality of life in CLL patients.